Organization

APHP-INSERM U1149 Universite Paris Diderot

20 abstracts

Abstract
Development and validation of AI-assisted transcriptomic signatures to personalize adjuvant chemotherapy in patients with resectable pancreatic ductal adenocarcinoma.
Org: Cancer Research Center of Marseille (CRCM), Digestive and Medical Oncology Department, Paul Brousse Hospital, Cancer Centre of Southeastern Ontario/Queen's University, Paoli-Calmettes Institute,
Abstract
Transcriptomic signatures of MSI-high metastatic colorectal cancer to predict efficacy of immune checkpoint inhibitors.
Org: Institut du Cancer Paris CARPEM, APHP-INSERM U1149 Universite Paris Diderot, Digestive Oncology Department, APHP.Centre - Université Paris Cité, Hôpital Européeen G. Pompidou,
Abstract
Efficacy of adjuvant therapy in patients (pts) with AJCC v8 stage IIIA cutaneous melanoma.
Org: Melanoma Institute Australia, The Netherlands Cancer Institute, Amsterdam University Medical Centers, The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, The Christie NHS Foundation Trust,
Abstract
Longitudinal assessment of cardiac involvement in Erdheim-Chester disease using cardiac magnetic resonance imaging.
Org: Hôpital Pitié-Salpêtrière, Service de Médecine Interne 2, Hôpital Pitié Salpêtrière, Assistance Publique Hôpitaux de Paris (AP-HP), Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany,
Abstract
Impact of positive resection margins on recurrence and survival following resection and adjuvant chemotherapy in pancreatic cancer: Results of the PRODIGE 24-CCTG PA-6 trial.
Org: Medical Oncology Department, Presidio Ospedaliero Santa Maria della Misericordia, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine, Italy, Lorraine Cancer Institute, Nancy N and J C Lewis Cancer and Research Pavilion, France, Institut de Cancérologie de Lorraine,
Abstract
Recurrent genetic alterations in primary central nervous system lymphoma of immunocompetent patients.
Org: APHP-INSERM U1149 Universite Paris Diderot, UPMC Health Plan, CRICM, UMR975, UMR U975,
Abstract
Predictive models of recurrence from transcriptomic signatures of the tumor microenvironment and cell cycle in stage III colon cancer from PETACC-8 and IDEA France trials.
Org: Institut du Cancer Paris CARPEM, APHP-INSERM U1149 Universite Paris Diderot, APHP.Centre - Université Paris Cité, Université Paris Cité, Hôpital Européeen G. Pompidou,
Abstract
Trastuzumab-deruxtecan in HER2-low metastatic/unresectable breast cancer: Real life data in two Parisian centers.
Org: Hôpital Tenon, Institut Universitaire de Cancérologie, Sorbonne Université, APHP-INSERM U1149 Universite Paris Diderot, Hôpital La Pitié-Salpêtrière,
Abstract
Identifying anatomopathological factors associated with a Oncotype DX 21-gene recurrence score higher than 25 in menopaused women.
Org: Assistance Publique des Hôpitaux de Paris, Hôpital Tenon, Institut Universitaire de Cancérologie, Sorbonne Université, APHP-INSERM U1149 Universite Paris Diderot,
Abstract
BRCA1 and RAD51 methylation impact on outcome in patients with advanced ovarian cancer: A PAOLA-1 ancillary study.
Org: APHP-INSERM U1149 Universite Paris Diderot, European Georges Pompidou Hospital, Centre de Recherche des Cordeliers, Université de Paris, Sorbonne Université,
Abstract
Effect of national multidisciplinary tumor boards on diagnostic stratification and therapeutic management in cancers of unknown primary.
Org: Institut Curie, Saint Cloud, France, Gustave Roussy Département d'Organisation du Parcours Patient, AP-HP at Saint-Louis Hospital, Hôpital Cochin Port-Royal, Centre Léon Bérard,
Abstract
Tebentafusp (tebe) in a real-world cohort of 72 French metastatic uveal melanoma (UM) patients (pts).
Org: Medical Oncology Department, Presidio Ospedaliero Santa Maria della Misericordia, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine, Italy, Institut Curie, Saint Cloud, France, APHP-INSERM U1149 Universite Paris Diderot, Curie Institute, Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy,
Abstract
Clinical benefit of personalized treatment following high throughput sequencing in metastatic melanoma: A national retrospective study.
Org: Dermatology and Skin Cancer Department, AP-HM Marseille, Dermatology Departement, Cochin Hospital, APHP,Université Paris Cité, Paris, France, CHU de Bordeaux, Cochin Hospital,
Abstract
19% PATIENTS WITH CHRONIC RHEUMATIC INFLAMMATORY DISEASES PRESENT AN UNFAVORABLE PREGNANCY OUTCOME: A DESCRIPTIVE ANALYSIS OF THE NATIONAL FRENCH SOCIAL SECURITY DATABASE
Org: Cochin Hospital, Assistance Publique hôpitaux de Paris, Rheumatology, Paris Cité University, APHP-INSERM U1149 Universite Paris Diderot,
Abstract
ARTERIAL STIFFNESS IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENTS: A CONTROLLED STUDY
Org: Paris-7 University, APHP-INSERM U1149 Universite Paris Diderot, Bichat Hospital, Paris-5 University, INSERM UMRS970,
Abstract
ASSOCIATION BETWEEN NUMBER AND SIZE OF CUTANEOUS TELANGIECTASIA WITH MICROCIRCULATION ABNORMALITIES DETECTED BY NAIFOLD VIDEOCAPILLAROSCOPY IN SYSTEMIC SCLEROSIS
Org: Cochin Hospital, APHP-INSERM U1149 Universite Paris Diderot, Paris Descartes University, INSERM U1016, Paris, France, Paris, France,
Abstract
ADALIMUMAB FOR IMMUNE RELATED INFERTILITY: EFFICACY AND SAFETY FROM PROSPECTIVE FRENCH MULTICENTER REGISTRY
Org: Sorbonne Université, AP-HP at Saint-Louis Hospital, Hôpital Saint Antoine, Assistance Publique Hôpitaux de Paris, Service de médecine interne et Inflammation-Immunopathology-Biotherapy Department (DMU i3), Paris, France,
Abstract
ANTI-DEGRADATIVE AND PRO-CHONDROGENIC PROPERTIES OF LIRAGLUTIDE, A GLUCAGON-LIKE-PEPTIDE 1 RECEPTOR AGONIST: EVIDENCE FROM PRECLINICAL STUDIES AND IMPLICATION FOR OSTEOARTHRITIS
Org: APHP-INSERM U1149 Universite Paris Diderot, Sorbonne University and Saint-Antoine Hospital, Rheumatology Department, Gregorio Marañon General University Hospital, Madrid, Spain, INSERM UMRS_938, CDR St-Antoine Paris,
Abstract
ASSOCIATION BETWEEN AN ENDOGLIN GENE POLYMORPHISM AND SYSTEMIC SCLEROSIS RELATED PULMONARY ARTERIAL HYPERTENSION
Org: Rheumatology and Clinical Immunology, Biomedical Engineering, Vascular diseases, University Medical Center, Groningen, Netherlands, Cochin and Hôtel-Dieu Hospitals, APHP-INSERM U1149 Universite Paris Diderot, Paris Cité University, Rheumatology, Society of Patients with Rheumatism, Cracow, Poland,
Abstract
BARRIERS TO PHYSICAL ACTIVITY COLLECTED BY THE IFAB QUESTIONNAIRE CORRELATE WITH LEVELS OF PHYSICAL ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS OR SPONDYLOARTHRITIS: A CROSS-SECTIONAL STUDY OF 150 PATIENTS
Org: Sorbonne Université, Inserm U567, Institut Pierre Louis d’Épidémiologie et de Santé Publique, PEPITES, Hôpital Charles Nicolle,